Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Here's Why Merck (MRK) is a Strong Growth Stock
10:46am, Friday, 14'th Nov 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NVDA Price Target Hikes, STUB Shows No Guidance, MRK Buying CDTX
10:00am, Friday, 14'th Nov 2025
Nvidia (NVDA) got bullish momentum from Wells Fargo and Morgan Stanley ahead of next week's earnings. Diane King Hall talks about what analysts expect from Nvidia's long-term prospects.
Merck to acquire Cidara Therapeutics for $9.2B
09:33am, Friday, 14'th Nov 2025
Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it has agreed to acquire Cidara Therapeutics Inc (NASDAQ:CDTX) in a $9.2 billion cash deal, paying $221.50 per share, more than double Cidara's stock pric
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
07:16am, Friday, 14'th Nov 2025
Merck & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the drugmaker's respiratory portfolio.
Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics
06:51am, Friday, 14'th Nov 2025
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
06:45am, Friday, 14'th Nov 2025
RAHWAY, N.J. & SAN DIEGO, Calif.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. (Nasdaq: CDTX) (“Cidara”), a biotechnology
Wall Street Breakfast Podcast: Merck Talks Send Cidara Soaring
06:09am, Friday, 14'th Nov 2025
Merck (MRK) is close to acquiring Cidara Therapeutics (CDTX) in a deal potentially exceeding $3.3 billion, with announcement expected soon. CDTX shares surged 85% on news of the potential acquisition,
Merck to acquire Cidara Therapeutics for $9.2B
04:29am, Friday, 14'th Nov 2025
Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it has agreed to acquire Cidara Therapeutics Inc (NASDAQ:CDTX) in a $9.2 billion cash deal, paying $221.50 per...
Merck & Co., Inc. $MRK Stake Decreased by Arvest Bank Trust Division
04:13am, Friday, 14'th Nov 2025
Arvest Bank Trust Division cut its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 43.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities a
Pulling Back for a Fresh Look at This Recent Pullback
07:06pm, Thursday, 13'th Nov 2025
Fed members are openly having second thoughts about further cuts to interest rates, especially with no new data on the jobs or inflation front.
Merck nearing deal for Cidara, FT reports
06:53pm, Thursday, 13'th Nov 2025
Merck is closing in on a deal to buy Cidara Therapeutics in a deal valuing the biotechnology company at a premium to its $3.3 billion market capitalization, the Financial Times reported on Thursday.
Merck to Participate in the Jefferies Global Healthcare Conference in London
06:45am, Thursday, 13'th Nov 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the Jefferies Global Healthcare Conference in London.
Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?
04:55am, Thursday, 13'th Nov 2025
Pfizer and Merck are two of the largest drug companies on the planet. Both companies are dealing with upcoming patent expirations.
2 Strong Healthcare Stock Picks for Value Investors
10:15am, Wednesday, 12'th Nov 2025
These two tried-and-tested healthcare giants have compelling portfolios and pipelines. Pfizer is moving on from the pandemic era, and a stream of acquisitions has bolstered its pipeline.
Merck & Co., Inc. $MRK Shares Sold by AGF Management Ltd.
04:08am, Wednesday, 12'th Nov 2025
AGF Management Ltd. lessened its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 33.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and
